Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Eisai_Co.,_Ltd.
|
| gptkbp:focusesOn |
precision oncology
cancer therapeutics |
| gptkbp:foundedIn |
2011
|
| gptkbp:founder |
gptkb:Keith_Flaherty
gptkb:Todd_R._Golub gptkb:Stuart_L._Schreiber |
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
H3 Biomedicine
|
| gptkbp:industry |
gptkb:biotechnology
pharmaceuticals |
| gptkbp:notableProduct |
gptkb:H3B-6527
gptkb:H3B-8800 H3B-6545 |
| gptkbp:parentCompany |
gptkb:Eisai_Co.,_Ltd.
|
| gptkbp:specializesIn |
genomics-driven drug discovery
targeted cancer therapies |
| gptkbp:website |
https://www.h3biomedicine.com/
|
| gptkbp:bfsParent |
gptkb:Stuart_Schreiber
|
| gptkbp:bfsLayer |
4
|